Retatrutide remains investigational as of 2026. It is not FDA-authorized and cannot be prescribed or compounded beyond scientific trial participation.Some compounding pharmacies will pivot to lawful solutions as enforcement pressures boost. Medications correctly on the bulk substances checklist deliver compliant profits opportunities.Retatrutide wo